Investor Presentaiton slide image

Investor Presentaiton

Raising FY 2020 Billings Guidance Excluding Ubimax 17 Billings Revenue €450-455m (previously around €450m) at least €450m (unchanged) Adj. EBITDA Margin around 56% (unchanged) Capital Expenditure Q3 2020 Investor Presentation €25 - 30m (unchanged) TeamViewer
View entire presentation